Multimodal detection of homologous recombination repair gene mutations (HRRm) in a phase II trial of olaparib plus abiraterone in metastatic castrate resistant prostate cancer (mCRPC)
Carr, TH Adelman, C Barnicle, A Kozarewa, I Luke, S Lai, Z Menon, S Hollis, S Dougherty, B Harrington, EA
Carr, TH
Adelman, C
Barnicle, A
Kozarewa, I
Luke, S
Lai, Z
Menon, S
Hollis, S
Dougherty, B
Harrington, EA
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Carr TH, Adelman C, Barnicle A, Kozarewa I, Luke S, Lai Z, et al. 97P Multimodal detection of homologous recombination repair gene mutations (HRRm) in a phase II trial of olaparib plus abiraterone in metastatic castrate resistant prostate cancer (mCRPC). Annals of Oncology. 2018;29(suppl_8).